Cargando…
Perspective: Is therapeutic plasma exchange a viable option for treating Alzheimer's disease?
Therapeutic plasma exchange, consisting of removing blood plasma and exchanging it with donated blood products, has been proposed for treating Alzheimer's disease (AD) to remove senescent or toxic factors. In preclinical studies, administration of plasma from young healthy mice to AD transgenic...
Autores principales: | Imbimbo, Bruno P., Ippati, Stefania, Ceravolo, Ferdinando, Watling, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087432/ https://www.ncbi.nlm.nih.gov/pubmed/32211508 http://dx.doi.org/10.1002/trc2.12004 |
Ejemplares similares
-
Initial failures of anti-tau antibodies in Alzheimer’s disease are reminiscent of the amyloid-β story
por: Imbimbo, Bruno P., et al.
Publicado: (2022) -
Can Anti–β-amyloid Monoclonal Antibodies Work in Autosomal Dominant Alzheimer Disease?
por: Imbimbo, Bruno P., et al.
Publicado: (2020) -
Why is adiabatic compressed air energy storage yet to become a viable energy storage option?
por: Barbour, Edward R., et al.
Publicado: (2021) -
MRSA and Skin Infections in Psoriatic Patients: Therapeutic Options and New Perspectives
por: Rizzetto, Giulio, et al.
Publicado: (2022) -
Argon: a novel therapeutic option to treat neuronal ischemia and reperfusion injuries?
por: Ulbrich, Felix, et al.
Publicado: (2015)